The recent sharp decline in stocks like IDFC, IndusInd, and HDFC may be a result of market corrections after continuous highs. This correction is expected, especially for sectors that have seen significant growth. However, the pharma sector has been outperforming after years of underperformance. It is difficult to predict the timing and extent of these corrections, but they are necessary for a balance between valuation and fundamentals.
| Subscribe To Our Free Newsletter |
